← Back
Data updated: Mar 10, 2026
GRANULES INDIA
Immunology
GRANULES INDIA is a generic drug manufacturer focused on Immunology.
2010
Since
4
Drugs
-
Trials
92
Approved (2yr)
Key Drugs
No active drugs
Recent Activity
NAPROXEN SODIUM 2026-01-24
Labeling
NAPROXEN SODIUM 2026-01-24
Labeling
NAPROXEN SODIUM 2026-01-24
Labeling
NAPROXEN SODIUM 2026-01-15
Labeling
METFORMIN HYDROCHLORIDE 2025-11-10
Manufacturing (CMC)
NAPROXEN SODIUM 2025-09-16
Labeling
NAPROXEN SODIUM 2025-09-16
Labeling
NAPROXEN SODIUM 2025-09-16
Labeling
NAPROXEN SODIUM 2025-09-16
Labeling
NAPROXEN SODIUM 2025-08-28
Labeling
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Immunology 100%
1 drugs
Pipeline Strength Pro
Loading...
Active (2)
Discontinued (2)
Company Info
- First Approval
- 2010-04-22
- Latest
- 2025-11-10
- Applications
- 4